Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 30, 2006
- Chuikyo Recommends Replacement of Current Prescription Form
January 30, 2006
- Josai Clinic Provides Comprehensive Care for Hair Loss
January 30, 2006
- Korosho to Demand Supply of Generics with Full Strengths
January 30, 2006
- Salaries Rose 1.7% in Healthcare & Welfare Sector in 2005: Korosho
January 30, 2006
- BUSINESS NEWS IN BRIEF
January 30, 2006
- R&D NEWS IN BRIEF
January 30, 2006
- Toyobo to Place Priority on Specialty Business Including Life Science
January 30, 2006
- Importance of "Clinical Mind" Stressed: JASDI Forum
January 30, 2006
- Chugai: Sales Up 11%, Profits Up 57.2%
January 30, 2006
- PI Study on Nanoplatin Approved in UK: NanoCarrier
January 30, 2006
- MCHC to Aim at Fusion of Pharmaceuticals and Diagnostics
January 30, 2006
- 3 Major DDS Preparations under Development by LTT Bio-Pharma
January 30, 2006
- Sankyo, Daiichi to Collaborate in Marketing 2nd Product
January 30, 2006
- Takeda Enters PII for the Anti-obesity Drug ATL-962 in Japan
January 30, 2006
- AMO to Focus on the Vision Care Life Cycle
January 30, 2006
- PHARMA DELEGATES
January 30, 2006
- NEW PRODUCTS
January 30, 2006
- PhRMA Announces Mr Ira Wolf as New Japan Representative
January 30, 2006
- REGULATORY NEWS IN BRIEF
January 30, 2006
ページ
Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…